Insights Articles
Articles
HHS-OIG Issues Guidance on Pharma DTC Prescription Drug Sales, but Key Legal Questions Remain
May 1, 2026
| Journal of Health Care Compliance

Go to the article

Related Capabilities
FDA & Life Sciences
Featured Lawyers
Person Brian Bohnenkamp
Brian A. Bohnenkamp
Partner
Government Matters & Regulation
Person Robert DeConti
Robert K. DeConti (Rob)
Partner
Government Matters & Regulation
Person Seth Lundy
Seth H. Lundy
Partner
Government Matters & Regulation
Person Kelly Reeves
Nikki Reeves
Partner
Government Matters & Regulation
Person John Shakow
John D. Shakow
Partner
Government Matters & Regulation
Person Christina Markus
Christina M. Markus (Chris)
Partner
Government Matters & Regulation
Person Kalle Deyette
Kalle E. Deyette
Senior Associate
Government Matters & Regulation
Explore King & Spalding
a blue and green background
Capabilities
FDA & Life Sciences
Learn More

The Best and Latest Insights
All in One Place.

Subscribe